Related references
Note: Only part of the references are listed.Effects of structural analogues of apelin-12 in acute myocardial infarction in rats
Oleg I. Pisarenko et al.
JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS (2013)
Apelin-13 limits infarct size and improves cardiac postischemic mechanical recovery only if given after ischemia
Raffaella Rastaldo et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2011)
Acute Cardiovascular Effects of Apelin in Humans Potential Role in Patients With Chronic Heart Failure
A. G. Japp et al.
CIRCULATION (2010)
Activation of catalase by apelin prevents oxidative stress-linked cardiac hypertrophy
Camille Foussal et al.
FEBS LETTERS (2010)
International Union of Basic and Clinical Pharmacology. LXXIV. Apelin Receptor Nomenclature, Distribution, Pharmacology, and Function
Sarah L. Pitkin et al.
PHARMACOLOGICAL REVIEWS (2010)
The role of the mitochondrial permeability transition pore in heart disease
Andrew P. Halestrap et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2009)
Plasma apelin concentration is depressed following acute myocardial infarction in man
Robin A. P. Weir et al.
EUROPEAN JOURNAL OF HEART FAILURE (2009)
Apelin protects heart against ischemia/reperfusion injury in rat
Xiang Jun Zeng et al.
PEPTIDES (2009)
The apelin-APJ system in heart failure pathophysiologic relevance and therapeutic potential
Alan G. Japp et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Apelin/APJ signaling system: a potential link between adipose tissue and endothelial angiogenic processes
O. Kunduzova et al.
FASEB JOURNAL (2008)
Vascular effects of apelin in vivo in man
Alan G. Japp et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury
Elizabeth Murphy et al.
PHYSIOLOGICAL REVIEWS (2008)
Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning
Peter Ferdinandy et al.
PHARMACOLOGICAL REVIEWS (2007)
Apelin-13 and apelin-36 exhibit direct cardioprotective activity against ischemiareperfusion injury
James C. Simpkin et al.
BASIC RESEARCH IN CARDIOLOGY (2007)
Apeliin activates L-arginine/nitric oxide synthase/nitric oxide pathway in rat aortas
Yue Xia Iia et al.
PEPTIDES (2007)
Apelin increases contractility in failing cardiac muscle
Tieying Dai et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Endothelial nitric oxide synthase in vascular disease -: From marvel to menace
U Förstermann et al.
CIRCULATION (2006)
Unravelling the roles of the apelin system: prospective therapeutic applications in heart failure and obesity
DK Lee et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2006)
Apelin protects myocardial injury induced by isoproterenol in rats
YX Jia et al.
REGULATORY PEPTIDES (2006)
Emerging roles of apelin in biology and medicine
MJ Kleinz et al.
PHARMACOLOGY & THERAPEUTICS (2005)
Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility
I Szokodi et al.
CIRCULATION RESEARCH (2002)
Oxidative injury due to chronic nitric oxide synthase inhibition in rat: effect of regular exercise on the heart
K Husain et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2002)
Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase
C Vickers et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Apelin, the natural ligand of the orphan seven-transmembrane receptor APJ, inhibits human immunodeficiency virus type 1 entry
M Cayabyab et al.
JOURNAL OF VIROLOGY (2000)
Status of myocardial antioxidants in ischemia-reperfusion injury
NS Dhalla et al.
CARDIOVASCULAR RESEARCH (2000)
Apelin peptides block the entry of human immunodeficiency virus (HIV)
MX Zou et al.
FEBS LETTERS (2000)
Share Paper
